한글목차

온코세르카증 치료 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 11억 1,000만 달러에서 2026년에는 11억 9,000만 달러에 이르고, CAGR 7.8%로 성장할 전망입니다. 지난 수년간의 성장 요인으로는 유행 지역에서의 이버멕틴과 독시사이클린 공급 부족, 병원 기반 유통 경로에 대한 의존도, 온코셀라증 관리에 대한 낮은 인식, 예방적 화학요법 프로그램 미비, 경구용 제제에 대한 의존도 등을 꼽을 수 있습니다.

온코세르카증 치료 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 15억 9,000만 달러에 이르고, CAGR은 7.4%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 옥시덱틴 및 지속형 제제 도입, 온라인 및 소매 약국 유통망 확대, 병용요법 개발, 박멸 프로그램에 대한 정부 및 NGO 자금 지원 증가, 지역 사회 기반 예방 전략 채택 등이 있습니다. 예측 기간 동안 주요 동향으로는 집단 투약(MDA) 프로그램 확대, 소아 및 고정 용량 제제 개발, 항월백혈병 치료에 대한 관심 증가, 경구 및 주사 치료 요법의 통합, 지역 사회 기반 및 정부 지원 치료 캠페인의 성장 등이 있습니다.

눈 관련 질환을 경험하는 환자 수가 증가함에 따라 향후 몇 년 동안 온코세르카증 치료제 시장의 성장을 견인할 것으로 예측됩니다. 눈과 관련된 문제에는 감염, 외상, 녹내장, 백내장과 같은 만성 질환 등 시력과 눈 건강에 영향을 미치는 다양한 질환이 포함됩니다. 눈 관련 질환을 앓고 있는 환자 증가는 주로 스크린 사용 시간 증가와 디지털 기기에 대한 장시간 노출에 기인합니다. 온코셀카증 치료는 안구 조직의 염증과 손상을 유발하는 기생충 감염을 제거함으로써 시력장애와 실명을 예방하고 관리하는 데 중요한 역할을 합니다. 예를 들어, 미국 질병예방통제센터(CDC)의 2024년 5월 기준 자료에 따르면, 40세 이상의 미국인 약 2,050만 명이 한쪽 눈 이상에 백내장을 가지고 있으며, 이는 같은 연령대의 17.2%에 해당합니다. 이 수치는 2028년까지 약 3,000만 명에 달할 것으로 예측됩니다. 따라서, 안질환의 유병률 증가는 온코셀카증 치료제 시장의 성장을 가속하고 있습니다.

수술에 대한 수요 증가는 향후 몇 년 동안 온코셀카증 치료 시장의 성장을 가속할 것으로 예측됩니다. 수술은 질병으로 인해 손상된 조직을 제거하거나 복구하기 위해 시행하는 의료 시술로, 약물 치료가 불충분하거나 합병증이 장기적으로 해를 끼칠 위험이 있을 때 종종 필요합니다. 이러한 수요 증가는 특정 환자에서 온코셀카증이 진행되어 시력 상실이나 신체적 변형과 같은 돌이킬 수 없는 결과를 막기 위해 수술이 필요한 고급 단계에 도달하는 사례가 증가하고 있기 때문입니다. 그 결과, 의료 시스템은 외과적 치료 능력을 확장하고 첨단 기술을 도입하고 있으며, 이는 전체 온코셀카증 치료 시장의 성장을 뒷받침하고 있습니다. 예를 들어, 미국에 본부를 둔 공인 미용 성형외과 의사를 대표하는 전문 기관인 국제미용성형외과학회(ISAPS)에 따르면, 2024년 6월 기준 2023년 전 세계에서 시행된 미용 시술은 약 3,500만 건으로 2022년 대비 3.4% 증가한 것으로 나타났습니다. 반면, 수술은 5.5% 증가하여 1,580만 건을 넘어섰습니다. 따라서 외과적 시술에 대한 수요 증가가 온코셀카증 치료 시장의 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Onchocerciasis treatment refers to the medical and therapeutic approaches used to control and eliminate infections caused by Onchocerca volvulus, the parasite responsible for river blindness, a disease that mainly affects the skin and eyes. The main objective of treatment is to remove microfilariae (immature larvae) and lower transmission rates, alleviate symptoms, and reduce the risk of vision impairment.

The primary drug types used in onchocerciasis treatment include ivermectin, doxycycline, albendazole, and moxidectin. Ivermectin is an antiparasitic drug widely used to treat several parasitic infections, including onchocerciasis, by destroying the parasite's larvae (microfilariae). Treatment strategies involve mass drug administration (MDA) and targeted therapy, with routes of administration including oral, injectable, and topical forms. Distribution channels comprise hospital pharmacies, retail pharmacies, and online pharmacies, and the treatments are utilized by end users such as hospitals and clinics, homecare settings, and government and non-governmental programs.

Tariffs have influenced the onchocerciasis treatment market by increasing the cost of imported active pharmaceutical ingredients (APIs) and finished drug formulations such as ivermectin, doxycycline, and moxidectin. Segments like fixed-dose combination therapies and long-acting oral tablets are particularly affected, with regions in Africa and Asia facing higher import duties. While tariffs have led to higher treatment costs and supply chain adjustments, they also encourage local pharmaceutical production and innovation in formulation development, improving long-term treatment accessibility.

The onchocerciasis treatment market research report is one of a series of new reports from The Business Research Company that provides onchocerciasis treatment market statistics, including onchocerciasis treatment industry global market size, regional shares, competitors with a onchocerciasis treatment market share, detailed onchocerciasis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the onchocerciasis treatment industry. This onchocerciasis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The onchocerciasis treatment market size has grown strongly in recent years. It will grow from $1.11 billion in 2025 to $1.19 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to limited availability of ivermectin and doxycycline in endemic regions, reliance on hospital-based distribution channels, low awareness of onchocerciasis management, inadequate preventive chemotherapy programs, dependency on oral formulations only.

The onchocerciasis treatment market size is expected to see strong growth in the next few years. It will grow to $1.59 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to introduction of moxidectin and long-acting formulations, expansion of online and retail pharmacy distribution, development of combination therapies, increased government and NGO funding for eradication programs, adoption of community-based preventive strategies. Major trends in the forecast period include expansion of mass drug administration (mda) programs, development of pediatric and fixed-dose formulations, increased focus on anti-wolbachia therapies, integration of oral and injectable treatment regimens, growth of community-based and government-supported treatment campaigns.

The growing number of patients experiencing eye-related conditions is anticipated to drive the growth of the onchocerciasis treatment market in the coming years. Eye-associated issues include a wide range of conditions that impact vision and ocular health, such as infections, injuries, and chronic disorders including glaucoma and cataracts. The increase in patients with eye-related issues is mainly attributed to rising screen time and prolonged exposure to digital devices. Onchocerciasis treatment plays a crucial role in preventing and managing vision impairment and blindness by eliminating the parasitic infection responsible for inflammation and damage to eye tissues. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, approximately 20.5 million Americans aged over 40 had cataracts in at least one eye, representing 17.2% of that population, and this number is expected to approach nearly 30 million by 2028. Therefore, the increasing prevalence of eye-related conditions is fueling the growth of the onchocerciasis treatment market.

The increasing demand for surgical procedures is expected to further propel the growth of the onchocerciasis treatment market in the coming years. Surgical procedures are medical interventions performed to remove or repair tissues damaged by disease and are often required when drug therapies are insufficient or when complications pose a risk of long-term harm. This growing demand is driven by the progression of onchocerciasis in certain patients to advanced stages, where surgery becomes necessary to prevent irreversible outcomes such as vision loss or physical disfigurement. Consequently, healthcare systems are expanding surgical capabilities and adopting advanced techniques, which supports overall market growth for onchocerciasis treatment. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional organization representing board-certified aesthetic plastic surgeons, nearly 35 million aesthetic procedures were carried out globally in 2023, reflecting a 3.4% increase from 2022, while surgical procedures rose by 5.5% to over 15.8 million. Therefore, the rising demand for surgical procedures is driving growth in the onchocerciasis treatment market.

Major companies operating in the onchocerciasis treatment market are emphasizing the development of novel antiparasitic drugs to enhance treatment efficacy and shorten therapy duration. Antiparasitic medications are pharmaceutical agents formulated to eliminate or suppress parasites such as worms and protozoa that cause infections in humans. For example, in December 2024, Medicines Development for Global Health (MDGH), an Australia-based non-profit biopharmaceutical organization, received approval from the Ghana Food and Drugs Authority for Moxidectin 2 mg oral tablets to treat river blindness in individuals aged four years and above. This approval allows Ghana to adopt community-based mass drug administration programs using moxidectin, which provides higher efficacy and longer-lasting benefits compared to ivermectin. Through this approval, MDGH aims to expand access to an effective new therapy for onchocerciasis and support large-scale treatment initiatives in endemic regions.

Major companies operating in the onchocerciasis treatment market are Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos - Fundacao Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc.

North America was the largest region in the onchocerciasis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onchocerciasis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the onchocerciasis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The onchocerciasis treatment market consists of revenues earned by entities providing services such as mass drug administration (MDA) campaigns, community-based health outreach, disease surveillance and diagnostics, vector control initiatives, and public health education. The market value includes the value of related goods sold by the service provider or included within the service offering. The onchocerciasis treatment market also includes sales of antiparasitic drugs, diagnostic kits, drug delivery tools, and protective supplies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Onchocerciasis Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses onchocerciasis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for onchocerciasis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The onchocerciasis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Drug Type: Ivermectin; Doxycycline; Albendazole; Moxidectin
• 2) By Treatment Strategy: Mass Drug Administration (MDA); Targeted Treatment
• 3) By Mode Of Administration: Oral; Injectables; Topical
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End User: Hospitals And Clinics; Home Care Settings; Government And Non-Governmental Programs
• Subsegments:
• 1) By Ivermectin: Oral Tablets; Community-Based Mass Drug Administration (MDA) Kits; Fixed-Dose Combination Therapies; Pediatric Formulations
• 2) By Doxycycline: Oral Capsules; Extended-Release Tablets; Combination With Anti-Wolbachia Therapy; Hospital-Based Prescription Treatments
• 3) By Albendazole: Single-Dose Oral Tablets; Combination Therapy With Ivermectin; Government-Supplied Preventive Chemotherapy Packages; Over-The-Counter (OTC) Formulations In Endemic Areas
• 4) By Moxidectin: Oral Tablets; Long-Acting Formulations; Adult-Only Dosing Regimens; Clinical Trial-Based Access Programs
• Companies Mentioned: Merck & Co. Inc.; Teva Pharmaceutical Industries Limited; Hetero Labs Limited; Sun Pharmaceutical Industries Limited; Intas Pharmaceuticals Limited; Dr. Reddy's Laboratories Inc.; Cipla Limited; Endo Inc.; Lupin Limited; Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos - Fundacao Oswaldo Cruz (Fiocruz); AMGIS Lifescience Ltd.; Drugs for Neglected Diseases initiative (DNDi); Rakshit Drugs Pvt. Ltd.; Hangzhou Longshine Bio-Tech Co. Ltd.; OREX Pharma Private Limited; Angle Bio Pharma Pvt. Ltd.; Senores Pharmaceuticals Inc.; Avenacy LLC; Dolphin Pharma; Cerata Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Onchocerciasis Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Onchocerciasis Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Onchocerciasis Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Onchocerciasis Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Expansion Of Mass Drug Administration (Mda) Programs
  • 4.2.2 Development Of Pediatric And Fixed-Dose Formulations
  • 4.2.3 Increased Focus On Anti-Wolbachia Therapies
  • 4.2.4 Integration Of Oral And Injectable Treatment Regimens
  • 4.2.5 Growth Of Community-Based And Government-Supported Treatment Campaigns

5. Onchocerciasis Treatment Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Home Care Settings
• 5.3 Government Programs
• 5.4 Non-Governmental Organizations (Ngos)
• 5.5 Community Health Centers

6. Onchocerciasis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Onchocerciasis Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Onchocerciasis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Onchocerciasis Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Onchocerciasis Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Onchocerciasis Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Onchocerciasis Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Onchocerciasis Treatment Market Segmentation

• 9.1. Global Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Ivermectin, Doxycycline, Albendazole, Moxidectin
• 9.2. Global Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Mass Drug Administration (MDA), Targeted Treatment
• 9.3. Global Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Injectables, Topical
• 9.4. Global Onchocerciasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• 9.5. Global Onchocerciasis Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs
• 9.6. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Tablets, Community-Based Mass Drug Administration (MDA) Kits, Fixed-Dose Combination Therapies, Pediatric Formulations
• 9.7. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Doxycycline, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Capsules, Extended-Release Tablets, Combination With Anti-Wolbachia Therapy, Hospital-Based Prescription Treatments
• 9.8. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single-Dose Oral Tablets, Combination Therapy With Ivermectin, Government-Supplied Preventive Chemotherapy Packages, Over-The-Counter (OTC) Formulations In Endemic Areas
• 9.9. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Moxidectin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Tablets, Long-Acting Formulations, Adult-Only Dosing Regimens, Clinical Trial-Based Access Programs

10. Onchocerciasis Treatment Market Regional And Country Analysis

• 10.1. Global Onchocerciasis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Onchocerciasis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Onchocerciasis Treatment Market

• 11.1. Asia-Pacific Onchocerciasis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Onchocerciasis Treatment Market

• 12.1. China Onchocerciasis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Onchocerciasis Treatment Market

• 13.1. India Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Onchocerciasis Treatment Market

• 14.1. Japan Onchocerciasis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Onchocerciasis Treatment Market

• 15.1. Australia Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Onchocerciasis Treatment Market

• 16.1. Indonesia Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Onchocerciasis Treatment Market

• 17.1. South Korea Onchocerciasis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Onchocerciasis Treatment Market

• 18.1. Taiwan Onchocerciasis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Onchocerciasis Treatment Market

• 19.1. South East Asia Onchocerciasis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Onchocerciasis Treatment Market

• 20.1. Western Europe Onchocerciasis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Onchocerciasis Treatment Market

• 21.1. UK Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Onchocerciasis Treatment Market

• 22.1. Germany Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Onchocerciasis Treatment Market

• 23.1. France Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Onchocerciasis Treatment Market

• 24.1. Italy Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Onchocerciasis Treatment Market

• 25.1. Spain Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Onchocerciasis Treatment Market

• 26.1. Eastern Europe Onchocerciasis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Onchocerciasis Treatment Market

• 27.1. Russia Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Onchocerciasis Treatment Market

• 28.1. North America Onchocerciasis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Onchocerciasis Treatment Market

• 29.1. USA Onchocerciasis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Onchocerciasis Treatment Market

• 30.1. Canada Onchocerciasis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Onchocerciasis Treatment Market

• 31.1. South America Onchocerciasis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Onchocerciasis Treatment Market

• 32.1. Brazil Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Onchocerciasis Treatment Market

• 33.1. Middle East Onchocerciasis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Onchocerciasis Treatment Market

• 34.1. Africa Onchocerciasis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Onchocerciasis Treatment Market, Segmentation By Drug Type, Segmentation By Treatment Strategy, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Onchocerciasis Treatment Market Regulatory and Investment Landscape

36. Onchocerciasis Treatment Market Competitive Landscape And Company Profiles

• 36.1. Onchocerciasis Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Onchocerciasis Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Onchocerciasis Treatment Market Company Profiles
  • 36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Hetero Labs Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Intas Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

37. Onchocerciasis Treatment Market Other Major And Innovative Companies

• Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos - Fundacao Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc.

38. Global Onchocerciasis Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Onchocerciasis Treatment Market

40. Onchocerciasis Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Onchocerciasis Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Onchocerciasis Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Onchocerciasis Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer